Emotions and scope effects in the monetary valuation of health María V. Avilés BlancoRaúl BreyJosé Luis Pinto Prades Original Paper 24 March 2017 Pages: 315 - 325
Economic and public health consequences of delayed access to medical care for migrants living with HIV in France Marlène GuillonMichel CelsePierre-Yves Geoffard Original Paper 25 March 2017 Pages: 327 - 340
Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation Dirk MüllerMarion DannerStephanie Stock Original Paper 05 April 2017 Pages: 341 - 353
The effectiveness of a population-based skin cancer screening program: evidence from Germany Micha KaiserJörg SchillerChristopher Schreckenberger Original Paper 28 March 2017 Pages: 355 - 367
Does socioeconomic status affect lengthy wait time in Canada? Evidence from Canadian Community Health Surveys Mohammad Hajizadeh Original Paper 07 April 2017 Pages: 369 - 383
Hospital heterogeneity: what drives the quality of health care Manhal AliReza SalehnejadMohaimen Mansur Original Paper Open access 24 April 2017 Pages: 385 - 408
Burden of suicide in Poland in 2012: how could it be measured and how big is it? Katarzyna OrlewskaEwa Orlewska Original Paper Open access 08 April 2017 Pages: 409 - 417
Using compensating variation to measure the costs of child disability in the UK Mariya MelnychukFrancesca SolmiStephen Morris Original Paper Open access 13 April 2017 Pages: 419 - 433
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age Hanna GyllenstenMichael WibergPetter Tinghög Original Paper Open access 09 May 2017 Pages: 435 - 446
Income disparities in healthcare use remain after controlling for healthcare need: evidence from Swedish register data on psoriasis and psoriatic arthritis Sofia LöfvendahlAnna JöudKatarina Steen Carlsson Original Paper Open access 19 May 2017 Pages: 447 - 462
The socio-economic impact of work disability due to inflammatory bowel disease in Brazil Renata de S. B. FróesAna Teresa Pugas CarvalhoHeitor S. de Souza Original Paper 18 May 2017 Pages: 463 - 470
Comment on “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany” Afschin Gandjour Commentary 06 February 2018 Pages: 471 - 472
Authors’ reply to Gandjour: “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany” Alexander KuhlmannJ.-Matthias Graf von der Schulenburg Reply 21 February 2018 Pages: 473 - 481